We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » R&D COSTS COULD HELP DECIDE DISEASE FOCUS, STUDY FINDS
R&D COSTS COULD HELP DECIDE DISEASE FOCUS, STUDY FINDS
May 7, 2004
Higher average clinical research and development (R&D) costs for drugs in some therapeutic classes are helping create an incentive for drugmakers to shift their efforts among disease states, according to a new study by the Tufts Center for the Study of Drug Development (CSDD).